RING finger palmitoylation of the endoplasmic reticulum Gp78 E3 ubiquitin ligase  by Fairbank, Maria et al.
FEBS Letters 586 (2012) 2488–2493journal homepage: www.FEBSLetters .orgRING ﬁnger palmitoylation of the endoplasmic reticulum Gp78 E3 ubiquitin ligase
Maria Fairbank a, Kun Huang b,c, Alaa El-Husseini b,1, Ivan R. Nabi a,⇑
aUniversity of British Columbia, Department of Cellular and Physiological Sciences, Vancouver, British Columbia, Canada
bUniversity of British Columbia, Department of Psychiatry and Brain Research Center, Vancouver, British Columbia, Canada
cUniversity of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, British Columbia, Canada
a r t i c l e i n f oArticle history:
Received 10 April 2012
Revised 30 May 2012
Accepted 1 June 2012
Available online 21 June 2012







Endoplasmic reticulum0014-5793/$36.00  2012 Federation of European Bio
http://dx.doi.org/10.1016/j.febslet.2012.06.011
⇑ Corresponding author. Address: Department o
Sciences, Life Sciences Institute, University of Bri
Sciences Mall, Vancouver, BC, Canada V6T 1Z3.
E-mail address: irnabi@mail.ubc.ca (I.R. Nabi).
1 Deceased.a b s t r a c t
Gp78 is an E3 ubiquitin ligase within the endoplasmic reticulum-associated degradation pathway.
We show that Flag-tagged gp78 undergoes sulfhydryl cysteine palmitoylation (S-palmitoylation)
within the RING ﬁnger motif, responsible for its ubiquitin ligase activity. Screening of 19 palmitoyl
acyl transferases (PATs) identiﬁed ﬁve that increased gp78 RING ﬁnger palmitoylation. Endoplasmic
reticulum (ER)-localized Myc-DHHC6 overexpression promoted the peripheral ER distribution of
Flag-gp78 while RING ﬁnger mutation and the palmitoylation inhibitor 2-bromopalmitate restricted
gp78 to the central ER. Palmitoylation of RING ﬁnger cysteines therefore regulates gp78 distribution
to the peripheral ER.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Gp78 is a critical E3 ubiquitin ligase in the endoplasmic reticu-
lum-associated degradation (ERAD) pathway that targets multiple
proteins for degradation via addition of polyubiquitin chains for
proteasome-dependent degradation [1]. The gp78 RING ﬁnger mo-
tif consists of a conserved series of cysteine and histidine residues
that bind two zinc atoms in a unique ‘cross-brace’ arrangement.
The speciﬁc structural conformation of the RING ﬁnger is a critical
component of its ubiquitin ligase function [2]. Here, we report, for
the ﬁrst time, RING ﬁnger palmitoylation of an endoplasmic retic-
ulum (ER) localized ubiquitin ligase, gp78. Sulfhydryl cysteine
palmitoylation (or S-palmitoylation), the addition of palmitate (a
16-carbon saturated fatty acid) to speciﬁc cysteine residues via a
thioester linkage, has been identiﬁed in various proteins including
many neuronal proteins and G protein-coupled receptors (GPCRs)
[3–5]. Palmitoylation, similar to phosphorylation, is a dynamic,
reversible post-translational modiﬁcation that regulates cellular
responses by altering receptor trafﬁcking, function and stability
[6,7]. Palmitoylation of gp78 is shown here to induce its distribu-
tion to the peripheral ER deﬁning a novel post-translationalchemical Societies. Published by E
f Cellular and Physiological
tish Columbia, 2350 Healthmodiﬁcation able to control the ER distribution of this key ubiqui-
tin ligase in ERAD.
2. Materials and methods
2.1. Plasmids and constructs
Mouse Flag-gp78 [8], 19 DHHC expression plasmids [9] and
GFP-Sec61b [10] are as previously described. The Flag-gp78 N-
terminal transmembrane domain construct was generated by
substituting L330 for a stop codon. All point mutations in Flag-
gp78 (C88/89A, C100A, C145A, C161A, C194/195A, C200/201A,
C337/340A, C352S, C360A, C371/374A) were generated using the
Quickchange Mutagenesis Kit (Stratagene) and sequences of
mutated DNA constructs were conﬁrmed.
2.2. Antibodies
Anti-Flag M2 and anti-calnexin were purchased from Sigma and
anti-Myc (clone 4A6) from Millipore. The rat IgM 3F3A monoclonal
antibody against gp78 is described in [11]. Fluorescently conjugated
secondary antibodies for immunocytochemistry were purchased
from Invitrogen. For immunoblotting experiments, HRP-conjugated
secondary antibodies were purchased from Jackson Immunore-
search. For the Odyssey Infrared Imaging System (Li-COR Biosci-
ence), anti-mouse IRDye 800 antibody was purchased from
Rockland and streptavidin-Cy5 from Invitrogen.lsevier B.V. All rights reserved.
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Cos7 cells were maintained in DMEM containing 10% fetal bo-
vine serum (FBS, MediCorp.), and supplemented with 0.2 mM L-
glutamine, 10 lg/ml penicillin, 10 lg/ml streptomycin, vitamins
and non-essential amino acids (all supplements from Invitrogen).
For transient transfection (24 h) of plasmid DNA into Cos7 cells,
Effectene Transfection Reagent (Qiagen) was used as described
by the manufacturer. 2-Bromohexadecanoic acid (2-bromopalmi-
tate (2-BP)) (Fluka) was used as described in the ﬁgure legends.
2.4. Immunoprecipitation, immunoblotting and immunoﬂuorescence
Anti-Flag immunoprecipitation, immunoblotting and immuno-
ﬂuorescence labeling were as previously described [12]. For immu-
noblot analysis, results are expressed as Mean ± S.E.M. and
statistical comparisons between groups were performed (Graph-
Pad PRISM) by using oneway analysis of variance (ANOVA) fol-
lowed by Tukey’s multiple comparison tests or a two-tailed
unpaired Student’s t test (Fig. 3D). For ﬂuorescence quantiﬁcation
experiments, ImagePro analysis software (Media Cybernetics)
was used to determine colocalization between two proteins by
Pearson’s coefﬁcient or by the percentage of Flag-gp78 localized
in the central ER [13].
2.5. Acyl-Biotin Exchange chemistry (or Biotin-BMCC labeling)
This method was adapted from [14]. During the anti-Flag
immunoprecipitation, supernatants were supplemented with
50 mM N-ethylmaleimide (NEM, Sigma). Each sample was divided
into two portions for treatment with or without (as a control) 1 M
hydroxylamine (HAM, Sigma) at pH 7.4 for 1 h at room tempera-
ture. Subsequently, all samples were incubated with 1 lM EZ-link
Biotin-BMCC (biotin-N-(6-(biotinamido)hexyl)-30-(20-pyridyldi-
thio)-propionamide biotinylation; Fisher Scientiﬁc) at pH 6.2 for
1 h at 4 C to label reactive cysteine residues. Following SDS–PAGE
and transfer to PVDF membranes, the Odyssey Infrared Imaging
System was used to visualize Biotin-BMCC-labeled Flag-gp78 withA
B C
Fig. 1. Gp78 is S-palmitoylated in the C-terminal domain. (A) Schematic of mouse gp78
residues). (B and C) Gp78 constructs (FL: Full-length Flag-gp78; FLDC TMD: Full-length F
N-terminal Flag-gp78 transmembrane domain) were tested for palmitoylation. Immuno
and anti-Flag antibody followed by IRDye 800 mouse antibody (to detect Flag-tagged
representative of three independent experiments.streptavidin-Cy5 and total Flag-gp78 with anti-Flag antibody and
anti-mouse IRDye 800 antibody.
3. Results
3.1. Gp78 is palmitoylated in the RING ﬁnger motif
To determine whether gp78 undergoes cysteine palmitoylation
or S-palmitoylation, we used Acyl-Biotin Exchange chemistry, also
referred to as Biotin-BMCC labeling [14]. The Biotin-BMCC method
labeled full-length Flag-gp78 (FL) and full-length Flag-gp78 lacking
N-terminal cysteines (FL DC TMD) (Fig. 1A and B). Furthermore, a
truncated gp78 construct containing only the N-terminal trans-
membrane domains (TMD) was not labeled (Fig. 1A and C). This
suggests that S-palmitoylation is localized to C-terminal cysteines,
all found within the RING ﬁnger domain (Fig. 2A). Mutation of indi-
vidual cysteines or combinations of two or three cysteines within
the RING ﬁnger all signiﬁcantly reduced gp78 palmitoylation
(Fig. 2B and D). However, the palmitoylation signal was only lost
when every RING ﬁnger cysteine was substituted with an alanine
(Fig. 2C and D), suggesting that all RING ﬁnger cysteines show a de-
gree of afﬁnity for S-palmitoylation.
We then investigated modulation of gp78 palmitoylation by
exogenously co-expressing palmitoyl acyl transferases (PATs), also
known as DHHC enzymes that mediate the addition of palmitoyl
CoA to proteins [15]. Using Biotin-BMCC labeling, we screened 19
Myc-DHHC enzymes and identiﬁed 5 DHHC enzymes (DHHC2,
DHHC6, DHHC11, DHHC13 (HIP14L) and DHHC24) that increased
gp78 palmitoylation by at least 1.5-fold (Fig. 3A and B). In Cos7
cells, these DHHC enzymes vary in their subcellular distributions:
DHHC2 localizes mostly to the plasma membrane, DHHC 13 is pre-
dominantly found in the Golgi, while DHHC6, DHHC 11 and
DHHC24 are all expressed in the ER (Fig. S1). We further explored
the role of ER-localized DHHC6. In the absence of all RING ﬁnger
cysteines, Flag-gp78 palmitoylation was not signiﬁcantly enhanced
by DHHC6 (Fig. 3C), suggesting that DHHC6 selectively targets
palmitoylation in the RING ﬁnger domain. Similarly, gp78 palmi-
toylation was reduced by 40% following a 6 h treatment with aconstructs used in the Biotin-BMCC labeling (⁄ identify the location of all cysteine
lag-gp78 absent of all nine cysteines in the transmembrane domain; TMD: truncated
blots were probed with streptavidin-Cy5 (to detect Biotin-BMCC-labeled proteins)
total proteins), and imaged with the Odyssey Infrared Imaging System. Data are
AB
C D
Fig. 2. Gp78 is S-palmitoylated on cysteines within the C-terminal RING ﬁnger domain. (A) The C-terminal of gp78 contains six cysteines all located within a RING ﬁnger
motif that is responsible for its ubiquitin ligase activity. Additional domains include an ubiquitin binding CUE motif and a p97/VCP binding domain. (B and C) Using site-
directed mutagenesis, cysteines in the RING ﬁnger motif were systematically substituted for alanines (C337, C340, C360, C371, C374) or a serine (C352) in full-length Flag-
gp78, generating a cysteine-free RING ﬁnger mutant (DC RING). Eight mutant constructs were tested for palmitoylation using Biotin-BMCC labeling. (D) Band densities were
ﬁrst normalized with respect to protein levels from anti-Flag immunoblots, and then each mutant was normalized to wild-type Flag-gp78 (control). (Mean ± S.E.M.; ⁄P < 0.05,
⁄⁄P < 0.01, ⁄⁄⁄P < 0.001 compared to wild-type. #P < 0.05 compared to the cysteine-free RING ﬁnger mutant). Data are representative of four to six experiments.
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(Fig. 3D), reinforcing the speciﬁcity of the S-palmitoylation signal
detected in the Biotin-BMCC labeling.
3.2. Gp78 palmitoylation regulates its ER distribution
Flag-gp78 is localized to both the peripheral and central ER and
its ubiquitin ligase activity has recently been shown to be initiated
in the peripheral ER [13]. Expression of Myc-DHHC6 reduced cen-
tral ER labeling of Flag-gp78, deﬁned by the central ER marker GFP-
Sec61b, relative to the periphery of the cell. Peripheral Flag-gp78
redistribution was not observed with Myc-DHHC 19 (Fig. 4), an
ER-localized DHHC enzyme that does not modulate gp78 palmitoy-
lation (Fig. 3B). As previously reported for the gp78 C352S RING
ﬁnger mutation [13], all RING ﬁnger Flag-gp78 mutants show in-
creased colocalization with calnexin (Fig. S2) that codistributes
extensively with central ER-localized GFP-Sec61b (data not
shown).
Distribution of the cysteine-free RING ﬁnger Flag-gp78 mutant
(DC RING) to the central ER was not affected by expression of
Myc-DHHC6 (Fig. 4). Similarly, following 2-BP treatment,Flag-gp78 accumulated in the GFP-Sec61b-deﬁned central ER and
the enhanced peripheral distribution of Flag-gp78 in the presence
of Myc-DHHC6 was reversed (Fig. S3). Peripheral ER-localized Flag-
gp78 colocalized extensively with 3F3 A anti-gp78 labeling (Fig. 5),
a marker for the peripheral, smooth ER [16,17]. Confocal image
analysis showed that all 5 DHHC enzymes that target gp78 pro-
moted a redistribution of Flag-gp78 to the peripheral ER (data
not shown). Gp78 palmitoylation therefore promotes its distribu-
tion to the peripheral ER.
4. Discussion
This study describes, for the ﬁrst time, palmitoylation of the
RING ﬁnger motif of an E3 ubiquitin ligase. Gp78 is an E3 ubiquitin
ligase in ERAD that can be palmitoylated by various PATs, including
ER-localized DHHC6. We show that palmitoylation promotes the
distribution of gp78 to the peripheral ER, the site of initiation of
gp78 ubiquitin ligase activity [13]. As a result, palmitoylation of
the gp78 RING ﬁnger motif may affect gp78 substrate degradation
in the ERAD pathway by disrupting the RING ﬁnger motif but also
by regulating gp78 ER distribution.
AB
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Fig. 3. S-palmitoylation by several DHHC enzymes of gp78 within the RING ﬁnger motif. (A and B) Cos7 cells were transiently transfected with either full-length Flag-gp78
alone or with a Myc-DHHC enzyme. Following anti-Flag immunoprecipitation, palmitoylation of Flag-gp78 was determined by Biotin-BMCC labeling. Quantiﬁcation of gp78
palmitoylation by individual DHHC enzymes as labeled by streptavidin-Cy5 was ﬁrst normalized to protein levels from anti-Flag immunoblots, and then to wild-type Flag-
gp78 alone (control). (C) Cos7 cells were transfected with the cysteine-free RING ﬁnger mutant (Flag-gp78 DC RING), in the presence and absence of Myc-DHHC6. Following
anti-Flag immunoprecipitation and Biotin-BMCC labeling, the Flag-gp78 DC RING palmitoylation signal was compared to wild-type Flag-gp78 alone (Mean ± S.E.M.;
⁄⁄⁄P < 0.001). (D) Anti-Flag immunoprecipitation and Biotin-BMCC labeling were used to determine the level of Flag-gp78 palmitoylation in Cos7 cells after a 6 h treatment
with a solvent (DMSO) or a broad inhibitor of palmitoylation, 2-bromopalmitate (100 nM 2-BP). Quantiﬁcation of gp78 palmitoylation was ﬁrst normalized to protein levels
from anti-Flag immunoblots, and then to wild-type Flag-gp78 alone (Mean ± S.E.M.; ⁄P < 0.05). Data are representative of three to ﬁve experiments.
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entially palmitoylated RING ﬁnger cysteine since all mutants dis-
played a 40–60% decrease in palmitoylation, with the exception
of the cysteine-free RING ﬁnger mutant (Fig. 2). These data rein-
force the concept that palmitoylation can occur on more than
one cysteine residue within membrane proteins, as seen for several
AMPA receptor subunits and the NMD A receptor [18,19]. A RING
ﬁnger mutant that contains an inhibitory point mutation in the
third cysteine (C352S) showed signiﬁcantly reduced palmitoyla-
tion levels (Fig. 2) and a reduced ability to generate polyubiquity-
lated substrates when co-transfected with HA-tagged ubiquitin[13]. Mutation of other RING ﬁnger cysteines will likely have a sim-
ilar effect, as suggested by the similar central ER distribution of
various RING ﬁnger cysteine mutants (Fig. S2). The speciﬁc rela-
tionship between RING ﬁnger palmitoylation and gp78 ubiquitin
ligase activity remains to be determined.
Screening analysis of 23 mammalian DHHC enzymes has dem-
onstrated that a number of substrates are differentially palmitoy-
lated by speciﬁc DHHC enzymes [20,21]. This is consistent with
our observation that 5 DHHC enzymes (DHHC2, DHHC6, DHHC11,
DHHC 13 and DHHC24) palmitoylate Flag-gp78 (Fig. 3). Overall,
these data are indicative of both speciﬁcity and redundancy
Fig. 4. DHHC6-mediated gp78 RING ﬁnger palmitoylation enhances its peripheral ER distribution. Cos7 cells were transiently transfected with a central ER marker (GFP-
Sec61b) and either Flag-gp78 wild-type (WT) or the cysteine-free RING ﬁnger mutant (Flag-gp78 DC RING), alone or in the presence of Myc-DHHC6 or Myc-DHHC 19, ﬁxed
and labeled with anti-Flag and anti-Myc and imaged by confocal microscopy. The percent intensity of Flag-gp78 (with and without DHHC enzyme) in the central ER was
determined by using GFP-Sec61b as a mask (Mean ± S.E.M.; ⁄P < 0.05 compared to Flag-gp78). Arrows indicate protein accumulation in the central ER. 22–42 cells per
condition were imaged from ﬁve to six independent experiments. Scale bar = 20 lm.
Fig. 5. Gp78 colocalizes with the 3F3A peripheral, smooth ER marker. Cos7 cells were transiently transfected with Flag-gp78 WT in the presence and absence of Myc-DHHC6,
ﬁxed and labeled with anti-Flag, anti-Myc and 3F3 A anti-gp78 antibodies and imaged by confocal microscopy. 18–24 cells per condition were imaged from six independent
experiments. Scale bar = 20 lm; zoom scale bar = 0.3 lm.
2492 M. Fairbank et al. / FEBS Letters 586 (2012) 2488–2493amongst DHHC enzymes that may have functional relevance in
light of the differential expression of DHHC enzymes in various tis-
sue types [9].
By electron microscopy, the ER can be separated into smooth
and rough, ribosome studded domains. These have more recently
been shown to correspond, in cultured cells, to the peripheral,
tubular ER and central, saccular ER [22]. However, mechanisms
that control protein distribution between these domains remain
poorly understood. We show that Ring ﬁnger palmitoylation tar-
gets gp78 to the peripheral ER (Figs. 4 and 5), the site of initiation
of gp78 ubiquitin ligase activity [13]. Mutation of RING ﬁnger
cysteines (Fig. S2) and inhibition of palmitoylation with 2-BP
(Fig. S3) both restrict gp78 to the central ER. By disrupting itsRING ﬁnger domain and promoting gp78 peripheral ER distribu-
tion, palmitoylation may therefore represent a mechanism to reg-
ulate and localize gp78 ubiquitin ligase activity to the peripheral
ER [12,13].
Since S-palmitoylation is highly dynamic, RING ﬁnger palmitoy-
lation may represent a novel mechanism for the regulation of the
activity, stability and cellular distribution of this ERAD-associated
ubiquitin ligase. Similarly, RING ﬁnger palmitoylation could have
signiﬁcant implications for the activity of other E3 ubiquitin ligases
and their ERAD substrates, ultimately affecting homeostatic and
pathological processes. Here, we propose that by regulating RING
ﬁnger integrity and gp78 ER distribution, palmitoylation may
impact on its E3 ubiquitin ligase function in ERAD. Whether RING
M. Fairbank et al. / FEBS Letters 586 (2012) 2488–2493 2493ﬁnger palmitoylation is gp78-speciﬁc or a general mechanism to
control the activity of RING ﬁnger ubiquitin ligases remains to be
determined.
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